News

A thermal analysis, which can be implemented on a small computer system, has been developed for PPM (periodic permanent-magnet)-focused rod-supported TWT (traveling-wave tube) helix structures. The ...
Immunotherapy has become a powerful clinical strategy for treating infectious diseases and cancer. Synthetic small-molecule toll-like receptor 7 (TLR7) ligands are attractive candidates as ...
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the SS&C GlobeOp Forward Redemption Indicator for June 2025 measured 2.27%, down from 2.34% in May ...
Structure–Activity Relationship Analysis of Imidazoquinolines with Toll-like Receptors 7 and 8 Selectivity and Enhanced Cytokine Induction Charles E. Schiaffo † , Ce Shi † , Zhengming Xiong ‡ , ...
When it comes to drop-leg holsters, three names dominate the conversation: Safariland, Blackhawk, and Alien Gear. Each brand has earned a reputation for reliability, innovation, and tactical ...
Background and Purpose—Systemic administration of Toll-like receptor (TLR) 4 and TLR9 agonists before cerebral ischemia have been shown to reduce ischemic injury by reprogramming the response of the ...
Purpose TLR7 and TLR8 (TLR7/8) are members of the Toll-Like Receptor family that recognize single strand RNA. Activation of TLR7/8 within immune cells elevates pro-inflammatory cytokines and type ...
Results The phenotypic characteristics of various immune cells were similar in both experimental groups; however, inhibition with miR antagonists reduced levels of human IL-2, IL-6, IL-10, and TNF-α ...
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, a leading science and technology company, today announced the presentation of detailed results from ...
Tesco, Britain's biggest food retailer, reported a better-than-expected pick-up in underlying sales growth in its first quarter and won market share from rivals, saying improvements in value ...
British scientific instruments maker Spectris said it would accept a 3.73 billion pound ($5.06 billion) bid from Advent if the U.S. private equity firm proceeds with a formal offer, sending its ...